Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Astor Q3 review: recovery takes shape - Nuways

ASTORThird party research12.11.2026 klo 09.47

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
Astor's Q3 showed a clear recovery from the weaker second quarter. Stronger deliveries, improved cost absorption and a pickup in order intake provide a firmer base for further growth, despite uneven progress across the portfolio.

Order intake regained momentum. Orders increased 23% yoy and 120% qoq to SEK 178m. Although intake still lagged deliveries, book-to-bill improved to 0.7x from 0.5x in Q2. October's SEK 33m Marstrom infrastructure award provides an encouraging start to Q4, with high quotation activity supporting the prospect of further contract wins.

Ammunity and NSG support growth, with Industry adding margin upside potential. Ammunity's expanded capacity offers substantial volume upside, with a Latvian strategic partnership and new European customers representing potential catalysts. NSG benefits from infrastructure protection demand, and Industry's defence ramp should lift utilisation and margins. Selective acquisitions provide an additional route to growth.

Action: D&A assumptions raised slightly following higher-than-expected charges in Q3, partly reflecting PPA amortisation.

Reiterate BUY, unchanged PT of SEK 27, based on a blend of DCF and peer group valuation